My insurance denied Wegovy. Are compounded GLP-1s my best option?

Short answer: No — compounded GLP‑1s are usually not the best first option. They carry safety, quality, legal, and coverage risks. You have safer, usually preferable alternatives to try first.

Why compounded GLP‑1s are risky

• They are not FDA‑approved products. Strength, purity and sterility can vary between compounding pharmacies.
• The FDA has issued warnings about compounded semaglutide products and about pharmacies selling unapproved “copies.”
• Insurance almost never covers compounded versions, so you’ll likely pay cash.
• Little or no clinical safety/efficacy data for the compounded formulations; dosing errors or contamination can cause harm.

Better next steps (practical, in order)

1. Get the denial reason and deadline. Call your insurer and ask whether it’s a coverage, prior‑authorization, or step‑therapy denial and what paperwork is required to appeal.
2. Ask your prescriber to file (or refile) a prior authorization/appeal with a detailed letter of medical necessity. Useful points: BMI, failed prior weight‑loss attempts, related medical conditions (hypertension, diabetes, OSA), and weighed risks if untreated. I can help draft that letter if you want.
3. Explore manufacturer support and savings:
   • Wegovy (semaglutide) — Novo Nordisk: check the Wegovy Savings Card and Novo Nordisk patient support programs (may lower out‑of‑pocket for commercially insured patients).
   • Zepbound (tirzepatide) — Eli Lilly: has patient support and savings programs for eligible patients. Tirzepatide (Zepbound) is an FDA‑approved option for chronic weight management and may be clinically appropriate if your doctor agrees.
     Note: manufacturer coupons typically aren’t usable for Medicare/Medicaid.
4. Consider other FDA‑approved prescription alternatives your insurer may cover:
   • Saxenda (liraglutide) — Novo Nordisk (approved for weight management)
   • Qsymia (phentermine/topiramate) and Contrave (naltrexone/bupropion) — oral alternatives that some plans will cover
     Your clinician can advise which is appropriate clinically.
5. Ask about step‑therapy exceptions. If your insurer requires trying cheaper meds first, your clinician can request an exception based on medical necessity.
6. Look for clinic help — many weight‑management practices and pharmacy benefit advocates assist with appeals and manufacturer enrollment. GoodRx/SingleCare may help with cash pricing if you pay out of pocket, but that’s not a substitute for a clinical decision.
7. If you still consider compounded as a last resort: only use a reputable, state‑licensed compounding pharmacy that follows USP sterility standards, ask for lot testing/coating info, and discuss risks with your prescriber — but be aware insurance and major medical societies advise caution.

If you want, I can:

• Help draft an appeal/letter of medical necessity for your doctor to submit.
• Look up the likely coverage options if you tell me the insurer and whether you have Medicare/Medicaid or commercial insurance.
• Summarize the pros/cons of Zepbound vs Wegovy for discussion with your clinician.

Which would you like to do next?